Dose optimisation following myocardial infarction

Dose optimisation of medicines for secondary prevention of MI provides evidence-based benefits, but studies show that ACE inhibitors and beta-blockers are prescribed at suboptimal doses on discharge and are not appropriately uptitrated thereafter. Here we look at the reasons why and the possible solutions.

Dose optimisation following myocardial infarction

Add yours ↓
Web design and marketing agency Leamington Spa